Bristol-Myers Squibb (BMY) Earnings Analysis

Bristol-Myers Squibb (BMY) next reports earnings on 2026-07-30, consensus EPS 1.6 USD. Last quarter (2026-04-30) it beat with EPS 1.58 USD vs 1.42 USD est (+11.3%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 17.07.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BMY next report earnings?

Next earnings date2026-07-30
Consensus EPS estimate1.6 USD
Revenue estimate11.74B

BMY earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-301.58 USD1.42 USD+11.3%Beat
2026-02-051.26 USD1.23 USD+2.4%Beat
2025-10-301.63 USD1.52 USD+7.2%Beat
2025-07-311.46 USD1.09 USD+33.9%Beat
2025-04-241.8 USD1.49 USD+20.8%Beat
2025-02-061.67 USD1.47 USD+13.6%Beat
2024-10-311.8 USD1.49 USD+20.8%Beat
2024-07-262.07 USD1.62 USD+27.8%Beat

Beat rate: 8/8 (100%) over reported quarters with consensus data.

BMY valuation and analyst view

Trailing P/E17.07
Trailing EPS3.56 USD
Price / book6.19
Dividend yield4.13%
Market cap124.29B
Analyst consensusHold (19 buy / 20 hold / 2 sell)
Avg price target59.39 USD

Related research pages

Frequently asked questions

When is Bristol-Myers Squibb (BMY)'s next earnings date?

Bristol-Myers Squibb is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 1.6 USD and revenue estimate of 11.74B.

Did BMY beat earnings last quarter?

In its 2026-04-30 report, BMY posted EPS of 1.58 USD versus a 1.42 USD estimate — a beat of 11.3%.

What is BMY's earnings track record?

Over the last 8 reported quarters with consensus data, BMY beat estimates 8 times (100%).

What is BMY's current P/E ratio and EPS?

BMY trades at a trailing P/E of 17.07 on trailing EPS of 3.5600493464434497 USD.

What do analysts rate BMY?

Analyst consensus is "Hold" across 41 ratings (0 strong buy, 19 buy, 20 hold, 2 sell, 0 strong sell). Average 12-month price target: 59.39 USD.